Zannes Maria 4
4 · bioAffinity Technologies, Inc. · Filed Jan 24, 2024
Insider Transaction Report
Form 4
Zannes Maria
DirectorPresident & CEO
Transactions
- Award
Common Stock
2024-01-01$1.48/sh+12,668$18,749→ 140,773 total - Award
Common Stock
2023-10-01$1.58/sh+11,867$18,750→ 128,105 total
Footnotes (2)
- [F1]Represents a grant from Issuer to Ms. Zannes of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.
- [F2]Represents a grant from the Issuer to Ms. Zannes of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year.